NCT00905593View on ClinicalTrials.gov

Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

APPROVED_FOR_MARKETINGEXPANDED_ACCESS
Timeline

Start Date

September 30, 2008

Primary Completion Date

April 30, 2011

Conditions
Chronic Myeloid Leukemia
Interventions
DRUG

Nilotinib

Trial Locations (2)

Unknown

Novartis Investigative Site, Guadalajara, Jalisco

Novartis Investigative Site, Mexico City

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY